-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX BIOSCIENCES SHARES FALL 22% AFTER CO RELEASES DATA FROM MID-STAGE STUDY OF ITS EXPERIMENTAL COMBINATION CANCER DRUG

路透·09/08/2026 14:17:00

登錄查看新聞詳情